Intellia Therapeutics, Inc. Business Finance Contracts & Agreements

16 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement Amending License and Collaboration Agreement Between Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. (November 22, 2022)
Modification Agreements
Intellia Therapeutics, Inc.
Biotechnology
2023
Intellia Therapeutics, Inc. Underwriting Agreement with Goldman Sachs & Co. LLC (Common Stock Offering)
Underwriting Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2022
Underwriting Agreement between Intellia Therapeutics, Inc. and Underwriters (Goldman Sachs, Jefferies, SVB Leerink, Barclays) for Common Stock Offering
Underwriting Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2021
Underwriting Agreement between Intellia Therapeutics, Inc. and Goldman Sachs & Co. LLC, Jefferies LLC, and SVB Leerink LLC (December 1, 2020)
Underwriting Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2020
Underwriting Agreement between Intellia Therapeutics, Inc. and Goldman Sachs & Co. LLC, Jefferies LLC, and SVB Leerink LLC (June 2, 2020)
Underwriting Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2020
Stock Purchase Agreement between Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. dated May 30, 2020
Stock Agreements
Intellia Therapeutics, Inc.
Biotechnology
MA
2020
Underwriting Agreement between Intellia Therapeutics, Inc. and Credit Suisse Securities (USA) LLC, Jefferies LLC, and Leerink Partners LLC for Common Stock Offering
Underwriting Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2017
Intellia Therapeutics, Inc. Common Stock Certificate Issued to Shareholder
Stock Agreements
Intellia Therapeutics, Inc.
Biotechnology
2016
Intellia Therapeutics, Inc. Common Stock Underwriting Agreement with Credit Suisse, Jefferies, and Leerink (2016)
Underwriting Agreements
Intellia Therapeutics, Inc.
Biotechnology
NY
2016
Description of Intellia Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Intellia Therapeutics, Inc.
Biotechnology
DE
2025
Description of Intellia Therapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Intellia Therapeutics, Inc.
Biotechnology
DE
2020
Common Stock Purchase Agreement between Intellia Therapeutics, Inc. and Novartis Institutes for Biomedical Research, Inc. (April 26, 2016)
Purchase Agreements
Intellia Therapeutics, Inc.
Biotechnology
DE
2016
Common Stock Purchase Agreement between Intellia Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc. (April 26, 2016)
Purchase Agreements
Intellia Therapeutics, Inc.
Biotechnology
DE
2016
Amendment No. 2 to Investors' Rights Agreement by and among Intellia Therapeutics, Inc. and Certain Investors
Investor Rights Agreements
Intellia Therapeutics, Inc.
Biotechnology
2016
Amendment No. 1 to Investors' Rights Agreement by and among Intellia Therapeutics, Inc. and Certain Investors
Investor Rights Agreements
Intellia Therapeutics, Inc.
Biotechnology
2016
Investors' Rights Agreement between Intellia Therapeutics, Inc. and Investors (August 20, 2015)
Investor Rights Agreements
Intellia Therapeutics, Inc.
Biotechnology
DE
2016